The Patent Finder
US

Abuse-Deterrent Pharmaceutical Compositions of Opioids and Other Drugs

US 8,557,291 Term ended
OverviewFamilyAssignmentsSources & methods

Term ended Mar 21, 2025 · High confidence

USPTO later recorded it as expired for non-payment on Nov 17, 2025.

Filed May 27, 2009 as application 12/473,073 · Granted Oct 15, 2013
Base term plus 623 days of patent term adjustment (USPTO delay)
Today
20 years from filing
Term ended Mar 21, 2025
2003 2026
Clock starts
Jul 7, 2003
Term ended
Mar 21, 2025
Granted
Oct 15, 2013
base term patent term adjustment after the term ends fee events Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
623
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 7,399,488, US 7,771,707, to Mar 21, 2025. The term already ends on or before that date, so the cap shortened nothing.
2 of 2
Maintenance fees paid
Two maintenance fees can end this term early, the ones due 3.5 and 7.5 years from grant; the third one's grace period runs past the term end. This counts the ones the record shows paid.
36
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.

This patent's term runs 623 days past its 20-year base term on prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. Confidence: High. from the record

How we calculated this date

One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
StepInputDate after this stepConfidence
Base term, 20 years from filingClock starts Jul 7, 2003, when application 10/614,866, the earliest non-provisional in its chain, was filed (this one was filed May 27, 2009)Jul 7, 2023High confidence
Continuity chainEvery parent in the chain resolvedno changeHigh confidence
Patent term adjustment+623 days, USPTO patent term adjustment recordMar 21, 2025High confidence
Terminal disclaimer capDisclaimer resolved from the filed document (refs US 7,399,488, US 7,771,707)resolves to Mar 21, 2025, no earlier than this term, so no changeHigh confidence
Patent term extensionNone on fileno changeHigh confidence
Fee events2 of 2 maintenance fees paidterm endedHigh confidence
USPTO status recordRecorded as expired for non-payment on Nov 17, 2025, after the term endedno changeHigh confidence
Computed term endThe steps above, in orderMar 21, 2025High confidence

Partial family

US 7,399,488Term ended
Mar 2025
Mar 2025
US 7,771,707In force
Oct 2028
Oct 2028
Application 12/112,937Abandoned
not computed
not computed
Application 12/112,993Abandoned
not computed
not computed
US 8,557,291this patent
Mar 2025
Mar 2025
US 8,449,909Term ended
Mar 2025
Mar 2025
US 8,840,928Term ended
Jul 2023
Jul 2023
US 9,044,398Term ended
Jul 2023
Jul 2023
8 of 36 applications in this family shown, earliest filings first. Partial: 5 of the 36 have no file history here, so a row comes from the patent's own record or names the application alone. The family may have others.

Assignments

Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
RecordedAssignorAssigneeConveyance
Dec 3, 2009
Reel 23600, frame 188
Rariy, Roman V.; Fleming, Alison B.; Hirsh, Jane; Klibanov, Alexander M.Collegium Pharmaceutical, Inc.Assignment of Assignor's Interest
Feb 13, 2020
Reel 51817, frame 583
Collegium Pharmaceutical, Inc.Biopharma Credit PLCSecurity Interest
Mar 22, 2022
Reel 59474, frame 526
Collegium Pharmaceutical, Inc.Biopharma Credit PLCAmended and Restated Patent Security Agreement
Dec 23, 2025
Reel 73308, frame 342
Biopharma Credit PLCCollegium Pharmaceutical, Inc.Release of Security Interest

Sources

Google Patents · The patent document at USPTO · Assignment records at USPTO

USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup

Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited